EA201391124A1 - Новые бензодиоксолпиперазиновые соединения - Google Patents
Новые бензодиоксолпиперазиновые соединенияInfo
- Publication number
- EA201391124A1 EA201391124A1 EA201391124A EA201391124A EA201391124A1 EA 201391124 A1 EA201391124 A1 EA 201391124A1 EA 201391124 A EA201391124 A EA 201391124A EA 201391124 A EA201391124 A EA 201391124A EA 201391124 A1 EA201391124 A1 EA 201391124A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- new
- benzodioxolpyperesine
- connections
- formula
- relates
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
- C07D317/66—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Abstract
Настоящее изобретение относится к новым двойным модуляторам рецепторов 5-HTи Dформулы (I)где n, Y, R, R, Rи Rявляются такими, как здесь описано, а также их фармацевтически приемлемым солям и эфирам. Также настоящее изобретение относится к получению соединений формулы (I), фармацевтическим композициям, их содержащим, и их применению в качестве лекарственных средств.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP11154780 | 2011-02-17 | ||
PCT/EP2012/052440 WO2012110470A1 (en) | 2011-02-17 | 2012-02-14 | Novel benzodioxole piperazine compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
EA201391124A1 true EA201391124A1 (ru) | 2014-02-28 |
Family
ID=45722618
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201391124A EA201391124A1 (ru) | 2011-02-17 | 2012-02-14 | Новые бензодиоксолпиперазиновые соединения |
Country Status (19)
Country | Link |
---|---|
US (1) | US8722683B2 (ru) |
EP (1) | EP2675798B1 (ru) |
JP (1) | JP2014505715A (ru) |
KR (1) | KR20140006953A (ru) |
CN (1) | CN103380122B (ru) |
AR (1) | AR085236A1 (ru) |
AU (1) | AU2012217150A1 (ru) |
BR (1) | BR112013020656A2 (ru) |
CA (1) | CA2823988A1 (ru) |
CO (1) | CO6761304A2 (ru) |
CR (1) | CR20130318A (ru) |
EA (1) | EA201391124A1 (ru) |
EC (1) | ECSP13012838A (ru) |
ES (1) | ES2546430T3 (ru) |
HK (1) | HK1189880A1 (ru) |
MA (1) | MA34946B1 (ru) |
MX (1) | MX2013008531A (ru) |
SG (1) | SG192819A1 (ru) |
WO (1) | WO2012110470A1 (ru) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106518841B (zh) * | 2015-09-15 | 2019-03-05 | 浙江京新药业股份有限公司 | 环己烷衍生物或其立体异构体或盐及其制备与应用 |
EP3495363B1 (en) | 2016-07-28 | 2023-08-23 | Shionogi & Co., Ltd | Nitrogen-containing condensed ring compounds having dopamine d3 receptor antagonistic effect |
US11447484B2 (en) | 2018-01-26 | 2022-09-20 | Shionogi & Co., Ltd. | Cyclic compound having dopamine D3 receptor antagonistic effect |
TW201938537A (zh) | 2018-01-26 | 2019-10-01 | 日商鹽野義製藥股份有限公司 | 具有多巴胺d3受體拮抗作用的稠環化合物 |
CN111770754B (zh) * | 2019-01-30 | 2023-09-19 | 江苏豪森药业集团有限公司 | 一种多环类衍生物调节剂、其制备方法和应用 |
CN110372557B (zh) * | 2019-08-06 | 2021-05-18 | 上海勋和医药科技有限公司 | 环己烷胺类d3/d2受体部分激动剂 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3347381B2 (ja) * | 1993-01-27 | 2002-11-20 | 協和醗酵工業株式会社 | ペットフード |
WO1996039133A1 (en) | 1995-06-06 | 1996-12-12 | Neurobiological Technologies, Inc. | Novel n-substituted-2-amino-3',4'-methylene-dioxypropiophenones |
EP1683790A1 (en) * | 2005-01-24 | 2006-07-26 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | 3,4-dihydro-2-naphthamide derivatives as selective dopamine D3 ligands |
HUP0500170A3 (en) * | 2005-02-03 | 2007-11-28 | Richter Gedeon Nyrt | Piperazine derivatives, process for producing them and pharmaceutical compositions containing them |
ES2399447T3 (es) | 2006-02-17 | 2013-04-01 | F. Hoffmann-La Roche Ag | Derivados benzoil-piperidina como moduladores de 5HT2/D3 |
CN101535258B (zh) * | 2006-10-31 | 2012-12-05 | 弗·哈夫曼-拉罗切有限公司 | 5ht2a和d3受体的醚衍生物双重调节剂 |
RU2480466C2 (ru) * | 2007-07-26 | 2013-04-27 | Ф.Хоффманн-Ля Рош Аг | Двойные модуляторы 5-ht2a и d3-рецепторов |
US7875610B2 (en) * | 2007-12-03 | 2011-01-25 | Richter Gedeon Nyrt. | Pyrimidinyl-piperazines useful as D3/D2 receptor ligands |
MX2011002628A (es) * | 2008-09-22 | 2011-04-05 | Hoffmann La Roche | Moduladores de los receptores d3 y 5-ht2a de piperazina. |
EP2334644A1 (en) * | 2008-09-23 | 2011-06-22 | F. Hoffmann-La Roche AG | Pyridinylpiperazin derivatives useful as modulators of dopamine d3 receptors |
US8586579B2 (en) * | 2010-06-21 | 2013-11-19 | Hoffmann-La Roche Inc. | Anellated pyridine compounds |
US8598357B2 (en) * | 2011-03-03 | 2013-12-03 | Hoffmann-La Roche Inc. | Benzodioxole piperidine compounds |
-
2012
- 2012-02-10 US US13/370,345 patent/US8722683B2/en not_active Expired - Fee Related
- 2012-02-14 BR BR112013020656A patent/BR112013020656A2/pt not_active IP Right Cessation
- 2012-02-14 ES ES12705101.9T patent/ES2546430T3/es active Active
- 2012-02-14 AU AU2012217150A patent/AU2012217150A1/en not_active Abandoned
- 2012-02-14 EA EA201391124A patent/EA201391124A1/ru unknown
- 2012-02-14 JP JP2013553896A patent/JP2014505715A/ja active Pending
- 2012-02-14 SG SG2013062443A patent/SG192819A1/en unknown
- 2012-02-14 WO PCT/EP2012/052440 patent/WO2012110470A1/en active Application Filing
- 2012-02-14 CA CA2823988A patent/CA2823988A1/en not_active Abandoned
- 2012-02-14 CN CN201280009057.7A patent/CN103380122B/zh not_active Expired - Fee Related
- 2012-02-14 EP EP12705101.9A patent/EP2675798B1/en not_active Not-in-force
- 2012-02-14 MA MA36210A patent/MA34946B1/fr unknown
- 2012-02-14 KR KR1020137024327A patent/KR20140006953A/ko not_active Application Discontinuation
- 2012-02-14 MX MX2013008531A patent/MX2013008531A/es active IP Right Grant
- 2012-02-15 AR ARP120100497A patent/AR085236A1/es not_active Application Discontinuation
-
2013
- 2013-06-21 CO CO13148386A patent/CO6761304A2/es not_active Application Discontinuation
- 2013-06-25 CR CR20130318A patent/CR20130318A/es unknown
- 2013-08-16 EC ECSP13012838 patent/ECSP13012838A/es unknown
-
2014
- 2014-03-21 HK HK14102838.6A patent/HK1189880A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA2823988A1 (en) | 2012-08-23 |
ES2546430T3 (es) | 2015-09-23 |
MA34946B1 (fr) | 2014-03-01 |
AR085236A1 (es) | 2013-09-18 |
US20130040948A1 (en) | 2013-02-14 |
ECSP13012838A (es) | 2013-09-30 |
HK1189880A1 (en) | 2014-06-20 |
EP2675798B1 (en) | 2015-07-01 |
JP2014505715A (ja) | 2014-03-06 |
KR20140006953A (ko) | 2014-01-16 |
CR20130318A (es) | 2013-09-03 |
BR112013020656A2 (pt) | 2016-10-18 |
US8722683B2 (en) | 2014-05-13 |
EP2675798A1 (en) | 2013-12-25 |
CO6761304A2 (es) | 2013-09-30 |
AU2012217150A1 (en) | 2013-05-02 |
SG192819A1 (en) | 2013-09-30 |
CN103380122A (zh) | 2013-10-30 |
MX2013008531A (es) | 2013-08-12 |
CN103380122B (zh) | 2015-04-29 |
WO2012110470A1 (en) | 2012-08-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201390576A1 (ru) | Противовирусные соединения | |
EA201591195A1 (ru) | Новые хинолоновые производные | |
EA201792046A1 (ru) | Модуляторы рецептора андрогенов и их применение | |
EA201490287A1 (ru) | Новые замещенные производные индола в качестве модуляторов гамма-секретазы | |
EA202090486A3 (ru) | Соединения для лечения спинальной мышечной атрофии | |
EA201600366A1 (ru) | Производные бензимидазол-пролина | |
EA201490320A1 (ru) | Соединения тетрагидропиридопиридина и тетрагидропиридопиримидина и их применение в качестве модуляторов рецептора c5a | |
EA201490471A1 (ru) | Пиридазиноновые соединения и их применение в качестве ингибиторов daao | |
EA201790781A3 (ru) | Противовирусные соединения | |
EA201201680A1 (ru) | Морфолинопиримидины и их применение в терапии | |
EA201391561A1 (ru) | Новые соединения-модуляторы gpr-119 | |
EA201790963A1 (ru) | Противовирусные соединения | |
EA201491362A1 (ru) | Анестезирующие соединения и способы их применения | |
NZ703162A (en) | Heterocyclic modulators of lipid synthesis | |
EA201390908A1 (ru) | Производные бицикло[3.2.1]октиламида и их применение | |
EA201391145A1 (ru) | Способы получения хинолиновых соединений и фармацевтических композиций, содержащих такие соединения | |
EA201500298A1 (ru) | Алкоксипиразолы в качестве активаторов растворимой гуанилатциклазы | |
EA201390969A1 (ru) | Модуляторы глюкагонового рецептора | |
EA201071329A1 (ru) | Диамидные производные адамантана и их применение | |
EA201492023A1 (ru) | Регуляторы пути комплемента и их применение | |
EA201291217A1 (ru) | ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, СОДЕРЖАЩИЕ ПРОИЗВОДНЫЕ 1-(β-D-ГЛЮКОПИРАНОЗИЛ)-2-ТИЕНИЛМЕТИЛБЕНЗОЛА КАК ИНГИБИТОРЫ НЗПГ | |
EA201490037A1 (ru) | Антагонисты trpv4 | |
EA201400854A1 (ru) | 4-(бензоимидазол-2-ил)тиазольные соединения и родственные аза производные | |
EA201300034A1 (ru) | Фармацевтические композиции, содержащие иматиниб или его фармацевтически приемлемую соль, и способы их получения | |
EA201391371A1 (ru) | Фармацевтическая композиция ситаглиптина |